Shanghai Realbio Technology Co., Ltd was founded in 2014, headquartered in the Pujiang High-tech Park, Minhang District, Shanghai,China. It is a national high-tech enterprise specializing in early accurate tumor detection. Regional centers have been established in Hangzhou, Qingdao, and other cities. The company operates independent medical testing laboratories in both Shanghai and Qingdao. Meanwhile, GMP-standard production workshops which cover an area of approximately 3000 square meters have been established in both Shanghai and Hunan.
With its core technology advantages in genetic testing, Realbio is dedicated to the development of multiple early non-invasive tumor detection products. It aims to achieve early cancer detection that is ultra-early, precise, safe, and highly compliant. By helping early-stage cancer patients seize the "golden window of opportunity" for clinical intervention, and by providing comprehensive automation of the testing process, it offers robust support for large-scale tumor testing and enables the digital upgrade of the IVD industries. Realbio has become a true leader in accurate tumor detection in China.
企业文化Corporate Culture
使命MISSION
To create a better life with advanced technology
Protecting human health
愿景VISION
Creating Beauty for Health
Creating Miracles for Life
Practicing dreams for science
价值观VALUES
Create a platform for employees
Guard the health for customers
Create value for society
China's leading company in accurate tumor detection
- 1000+Technology service projects
- 500+Partner medical institutions
- 200+Invention patents and software works
- 60%+Proportion of master degree or above
- 30W+Number of samples tested
- Shanghai Realbio Medical Laboratory
- Qingdao Realbio Precision Medical Laboratory
- Hangzhou Realbio Bioinformatics Analysis Center
- Hunan Realbio GMP standard production workshop
-
Shanghai Realbio Medical Laboratory was registered in August 2020 and occupies an area of approximately 800 square meters. Realbio Laboratory possesses dual qualifications, including the "Medical Institution Practice License" and the "Technical Audit Certificate for Clinical Genetic Amplification Testing Laboratory". The laboratory is equipped with advanced equipment such as the MGI-SEQ200 and Illumina NextSeq 550Dx sequencing platforms, fully automated nucleic acid extractors, fluorescent quantitative PCR instruments, and other state-of-the-art devices. Leveraging a profound accumulation of genetic methylation testing technology, an automated bioinformatics data analysis system, and a rigorous quality management system, Realbio Laboratory provides precise and efficient technical support for early non-invasive tumor detection.
The core technical team has rich experience in product research and development, as well as significant project management experience, in the fields of clinical diagnostics and tumor genetic testing. The team members are well-known experts, scholars, and high-level scientific researchers in this field. They possess strong scientific research capabilities and have extensive experience in clinical diagnostics.